Gallant Pharma Pleads Guilty In Black-Market Drug Case

Law360, Los Angeles (December 2, 2013, 9:32 PM EST) -- A Virginia-based pharmaceuticals seller and its co-owner pled guilty Monday to fraud and selling misbranded drugs imported from Europe and elsewhere in an operation prosecutors say brought unmonitored black-market prescription drugs into the mainstream.

The U.S. Department of Justice said Monday that Gallant Pharma International Inc. had copped to two counts of importation fraud, five counts of selling misbranded drugs and five counts of distributing prescription drugs without a license.

Meanwhile, co-owner and co-founder Syed Huda pled guilty to one count each of importation fraud, selling...
To view the full article, register now.